Preoperative plasma BNP concentrations: Do they improve our care of high-risk non-cardiac surgical patients?

British Journal of Anaesthesia

Volumn 99, Issue 2, 2007, Pages 151-154

  Sear, J W ^a   Howard Alpe, G ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE;

CONGESTIVE HEART FAILURE; CORONARY ARTERY BYPASS GRAFT; CRITICAL ILLNESS; DYSPNEA; EDITORIAL; HEART ARRHYTHMIA; HEART SURGERY; HEART TRANSPLANTATION; HEART VENTRICLE HYPERTROPHY; HIGH RISK PATIENT; HUMAN; HYPERTENSION; INTENSIVE CARE UNIT; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; MAJOR SURGERY; MORBIDITY; NONHUMAN; PATIENT CARE; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; SURGICAL MORTALITY; SURGICAL PATIENT; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 34547869227     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aem205     Document Type: Editorial

References (33)

1. Eagle KA, Berger PB, Calkins H, et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery - executive summary a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Circulation 2002; 105: 1257-67
2. NCEPOD. Then and Now: Report of the National Confidential Enquiry into Perioperative Deaths 2000
3. Howard-Alpe GM, Sear JW, Foex P. Methods of detecting atherosclerosis in non-cardiac surgical patients; the role of biochemical markers. Br J Anaesth 2006, 97: 758-69
4. Khuseyinova N, Koenig W. Biomarkers of outcome from cardiovascular disease. Curr Opin.Crit Care 2006; 12: 412-9
5. Galley HF. Editorial II: Solid as a ROC. Br J Anaesth 2004; 93 623-6
6. Mueller C, Scholer A, Laule-Kilian K, et al. Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med 2004; 350: 647-54
7. Ueda R, Yokouchi M, Suzuki T, Otomo E, Katagiri T. Prognostic value of high plasma brain natriuretic peptide concentrations in very elderly persons. Am J Med 2003; 114: 266-70
8. Wang TJ, Larson MG, Levy D, et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 2004, 350: 655-63
9. Uusimaa P, Tokola H, Ylitalo A. et al. Plasma B-type natriuretic peptide reflects left ventricular hypertrophy and diastolic function in hypertension. Int J Cardiol 2004; 97: 251-6
10. Grabowski M, Filipiak KJ, Karpinski G, et al. Prognostic value of B-type natriuretic peptide levels on admission in patients with acute ST elevation myocardial infarction. Acta Cardiol 2005; 60: 537-42
11. Ezekowitz JA, Theroux P, Chang W, et al. N-terminal- pro-brain natriuretic peptide and the timing, extent and mortality in ST elevation myocardial infarction. Can J Cardiol 2006; 22: 393-7
12. de Winter RJ, Stroobants A, Koch KT, et al. Plasma N-terminal pro-B-type natriuretic peptide for prediction of death or nonfatal myocardial infarction following percutaneous coronary intervention. Am J Cardiol 2004; 94: 1481-5
13. Staub D, Nusbaumer C, Zellweger MJ, et al. Use of B-type natriuretic peptide in the detection of myocardial ischemia. Am Heart J 2006; 151: 1223-30
14. Hutfless R, Kazanegra R, Madani M, et al. Utility of B-type natriuretic peptide in predicting postoperative complications and outcomes in patients undergoing heart surgery. J Am Coll Cardiol 2004; 43: 1873-9
15. Provenchere S, Berroeta C, Reynaud C, et al Plasma brain natriuretic peptide and cardiac troponin I concentrations after adult cardiac surgery: Association with postoperative cardiac dysfunction and 1-year mortality. Crit Care Med 2006; 34: 995-1000
16. Mekontso-Dessap A, Tual L, Kirsch M, et al. B-type natriuretic peptide to assess haemodynamic status after cardiac surgery. Br J Anaesth 2006, 97: 777-82
17. Wazni OM, Martin DO, Marrouche NF, et al. Plasma B-type natriuretic peptide levels predict postoperative atrial fibrillation in patients undergoing cardiac surgery. Circulation 2004; 110: 124-7
18. Cuthbertson BH, McKeown A, Croal BL, Mutch WJ, Hillis GS. Utility of B-type natriuretic peptide in predicting the level of peri- and postoperative cardiovascular support required after coronary artery bypass grafting. Crit Care Med 2005; 33: 437-42
19. Cerrahoglu M, Iskesen I, Tekin C, et al. N-terminal ProBNP levels can predict cardiac failure after cardiac surgery. Circ J 2007, 71: 79-83
20. Kerbaul F, Giorgi R, Oddoze C, et al. High concentrations of N-BNP are related to non-infectious severe SIRS associated with cardiovascular dysfunction occurring after off-pump coronary artery surgery. Br J Anaesth 2004; 93: 639-44
21. Guerin V, Ayed SB, Varnous S, et al. Release of brain natriuretic-related peptides (BNP, NT-proBNP) and cardiac troponins (cTnT, cTnI) in on-pump and off-pump coronary artery bypass surgery. Surg Today 2006; 36: 783-9
22. Gardner RS, Chong KS, Murday AJ, Morton JJ, McDonagh TA. N-terminal brain natriuretic peptide is predictive of death after cardiac transplantation. Heart 2006; 92: 121-3
23. Berendes E, Van Aken H, Raufhake C, et al. Differential secretion of atrial and brain natriuretic peptide in critically ill patients. Anesth Analg 2001; 93: 676-825
24. Brueckmann M, Huhle G, Lang S, et al. Prognostic value of plasma N-terminal pro-brain natriuretic peptide in patients with severe sepsis. Circulation 2005; 112: 527-34
25. Almog Y, Novack V, Megralishvili R, et al. Plasma level of N terminal pro-brain natriuretic peptide as a prognostic marker in critically ill patients. Anesth Analg 2006; 102: 1809-15
26. Cuthbertson BH, Patel RP, Croal BL, Barclay J, Hillis GS. B-type natriuretic peptide and the prediction of outcome in patients admitted to intensive care. Anaesthesia 2005; 60: 16-21
27. Manikandan R, Nathaniel C, Lewis P, et al. Troponin T and N-terminal pro-brain natriuretic peptide changes in patients undergoing transurethal resection of prostate. J Urol 2005, 174: 1892-5
28. Yeh HM, Lau HP, Lin JM, et al. Preoperative plasma N-terminal pro-brain natriuretic peptide as a marker of cardiac risk in patients undergoing elective non-cardiac surgery. Br J Surg 2005; 92: 1041-5
29. Feringa, HH, Bax JJ, Elhendy A, et al. Association of plasma N-terminal pro-B-type natriuretic peptide with postoperative cardiac events in patients undergoing surgery for abdominal aortic aneurysm or leg bypass. Am J Cardiol 2006; 98: 111-5
30. Dernellis J, Panaretou M. Assesment of cardiac risk before non-cardiac surgery: Brain natriuretic peptide in 1590 patients. Heart 2006, 92: 1645-50
31. Gibson SC, Payne CJ, Byrne DS, et al. B-type natriuretic peptide predicts cardiac morbidity and mortality after major surgery. Br J Surg 2007; 94: 903-9
32. Cuthbertson BH, Amiri AR, Croal BL, et al. The utility of B-type natriuretic peptide in predicting perioperative cardiac events in patients undergoing major non-cardiac surgery. Br J Anaesth 2007; 99: 170-6
33. Mahla E, Baumann A, Rehak P, et al. N-terminal pro-brain natriuretic peptide identifies patients at high risk for adverse cardiac outcome after vascular surgery. Anesthesiology 2007, 106: 1088-95